Lisa L. Wei

4.5k total citations
77 papers, 3.5k citations indexed

About

Lisa L. Wei is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Lisa L. Wei has authored 77 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 32 papers in Genetics and 26 papers in Ophthalmology. Recurrent topics in Lisa L. Wei's work include Retinal Development and Disorders (27 papers), Retinal Diseases and Treatments (22 papers) and Estrogen and related hormone effects (18 papers). Lisa L. Wei is often cited by papers focused on Retinal Development and Disorders (27 papers), Retinal Diseases and Treatments (22 papers) and Estrogen and related hormone effects (18 papers). Lisa L. Wei collaborates with scholars based in United States, Canada and Japan. Lisa L. Wei's co-authors include Kathryn B. Horwitz, Peter Gehlbach, Peter A. Campochiaro, Keisuke Mori, William M. Wood, Mary D. Francis, Nancy Krett, Elia J. Duh, D. F. Gordon and Paul A. Sieving and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lisa L. Wei

76 papers receiving 3.4k citations

Peers

Lisa L. Wei

GENET

OPHTH

RNMI

ONCOL

Peggy S. Zelenka United States

S. Patricia Becerra United States

Andreas Marquardt Germany

Michael A. Blanar United States

Hendrik Gille Germany

Patricia J. Gallagher United States

Kei-ichi Nakayama Japan

Alain Eychène France

C. Richard Savage United States

Pierre de la Grange France

Peggy S. Zelenka United States

Lisa L. Wei

2.0k ×0.9

253 ×0.2

GENET

339 ×0.3

OPHTH

298 ×0.5

RNMI

323 ×0.7

ONCOL

Citations per year, relative to Lisa L. Wei Lisa L. Wei (= 1×) peers Peggy S. Zelenka

Countries citing papers authored by Lisa L. Wei

Since Specialization

Citations

This map shows the geographic impact of Lisa L. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa L. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa L. Wei more than expected).

Fields of papers citing papers by Lisa L. Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa L. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa L. Wei. The network helps show where Lisa L. Wei may publish in the future.

Co-authorship network of co-authors of Lisa L. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa L. Wei. A scholar is included among the top collaborators of Lisa L. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa L. Wei. Lisa L. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vijayasarathy, Camasamudram, Catherine A. Cukras, Henry E. Wiley, et al.. (2021). Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial. Molecular Therapy. 29(6). 2030–2040. 26 indexed citations

Wei, Lisa L., Diane L. Trinh, Rhonda E. Ries, et al.. (2020). Integrative Analysis of Single-Cell RNA-Seq and ATAC-Seq Data across Treatment Time Points in Pediatric AML. Blood. 136(Supplement 1). 29–29. 2 indexed citations

Zeng, Yong, Ryan F. Boyd, Joshua T. Bartoe, et al.. (2020). “Para-retinal” Vector Administration into the Deep Vitreous Enhances Retinal Transgene Expression. Molecular Therapy — Methods & Clinical Development. 18. 422–427. 7 indexed citations

Cukras, Catherine A., Henry E. Wiley, Brett G. Jeffrey, et al.. (2018). Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery. Molecular Therapy. 26(9). 2282–2294. 178 indexed citations

Wei, Lisa L., Diane L. Trinh, Soheil Meshinchi, & Marco A. Marra. (2017). Single Cell Transcriptome Analysis Reveals Changing Levels and Distributions of Stemness across Disease States in Pediatric AML. Blood. 130. 3953–3953. 1 indexed citations

Marangoni, Dario, Zhijian Wu, Henry E. Wiley, et al.. (2014). Preclinical Safety Evaluation of a Recombinant AAV8 Vector for X-Linked Retinoschisis After Intravitreal Administration in Rabbits. PubMed. 25(4). 202–211. 26 indexed citations

Wei, Lisa L., et al.. (2014). Instrument-based vision screening: Update and review. Contemporary pediatrics. 7 indexed citations

Beer, Philip, David J. H. F. Knapp, Nagarajan Kannan, et al.. (2014). A Dominant-Negative Isoform of IKAROS Expands Primitive Normal Human Hematopoietic Cells. Stem Cell Reports. 3(5). 841–857. 19 indexed citations

Mori, Keisuke, T. Shoji, Peter Gehlbach, et al.. (2014). Ocular Localization and Transduction by Adenoviral Vectors Are Serotype-Dependent and Can Be Modified by Inclusion of RGD Fiber Modifications. PLoS ONE. 9(9). e108071–e108071. 15 indexed citations

10.

Hamilton, Melissa, Gordon A. Byrnes, Jason G. Gall, et al.. (2008). Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.. PubMed. 14. 2535–46. 26 indexed citations

11.

Demetriades, Anna M., Tye Deering, Hansheng Liu, et al.. (2008). Trans-scleral Delivery of Antiangiogenic Proteins. Journal of Ocular Pharmacology and Therapeutics. 24(1). 70–79. 26 indexed citations

12.

McVey, Duncan, et al.. (2008). Repeat Administration of Proteins to the Eye With a Single Intraocular Injection of an Adenovirus Vector. Molecular Therapy. 16(8). 1444–1449. 5 indexed citations

13.

Mori, Keisuke, Akihiko Okuda, Tomoko Ito, et al.. (2005). Empty E1–, E3–, E4+ and Empty E1–, E3–, E4– Adenoviral Vectors Inhibit Retinal Neovascularization. Investigative Ophthalmology & Visual Science. 46(13). 5221–5221. 1 indexed citations

14.

Imai, Daisuke, Shin Yoneya, Peter Gehlbach, Lisa L. Wei, & Keisuke Mori. (2004). Intraocular gene transfer of pigment epithelium‐derived factor rescues photoreceptors from light‐induced cell death. Journal of Cellular Physiology. 202(2). 570–578. 48 indexed citations

15.

Carrion, Miguel, Melissa Hamilton, Brent T. Harris, et al.. (2003). Ocular Sublocalization and Pharmacokinetics of Expression of Pigment Epithelium-Derived Factor in Murine Eyes Following Adenovirus-Based Intravitreous Gene Delivery. Investigative Ophthalmology & Visual Science. 44(13). 3587–3587. 1 indexed citations

16.

Miller, Marijean M., et al.. (2003). Corneoscleral transplantation in congenital corneal staphyloma and Peters' anomaly. Ophthalmic Genetics. 24(1). 59–63. 9 indexed citations

17.

Gehlbach, Peter, Anna M. Demetriades, Satoru Yamamoto, et al.. (2003). Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Therapy. 10(8). 637–646. 62 indexed citations

18.

Mori, Keisuke, Peter Gehlbach, Akira Ando, et al.. (2002). Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.. PubMed. 43(7). 2428–34. 152 indexed citations

19.

Wei, Lisa L., Susanna S. Park, & Daniel J. Skiest. (2002). PREVALENCE OF VISUAL SYMPTOMS AMONG PATIENTS WITH NEWLY DIAGNOSED CYTOMEGALOVIRUS RETINITIS. Retina. 22(3). 278–282. 17 indexed citations

20.

Horwitz, Kathryn B., Mary D. Francis, & Lisa L. Wei. (1985). Hormone-dependent Covalent Modification and Processing of Human Progesterone Receptors in the Nucleus. DNA. 4(6). 451–460. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact